Consumer Health Neurology
Thermo Fisher’s Oncomine Dx Target Test Receives FDA Approval to Guide Treatment with Servier’s VORANIGO® for Grade 2 IDH-Mutant Glioma
Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only FDA-approved treatment for Grade 2 I...
October 22, 2024 | News
Sunbird Bio Secures $14M in New Funding from Eli Lilly and EDBI to Advance Blood-Based Diagnostic Technology for Neurological Disorders
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to furth...
October 17, 2024 | News
Lenovo Collaborates with Innovations in Dementia to Launch AI-Powered ‘Alzheimer’s Intelligence’ Avatar for Early Dementia Support
Lenovo™ in collaboration with Innovations in Dementia, launched Alzheimer’s Intelligence, a photorealistic 3D avatar with custom AI based ...
October 16, 2024 | News
South Korea's Neurophet and AriBio Join Forces to Develop Advanced Diagnostic Platform for Alzheimer's
Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collabor...
October 16, 2024 | News
UCSF’s Laura Seeholzer Wins 2024 Eppendorf & Science Prize for Neurobiology for Breakthrough in Airway Protection Research
The American scientist Laura Seeholzer, Ph.D., Postdoctoral Fellow at the University of California, San Francisco, USA, has won the 2024 Eppendorf & Sc...
October 15, 2024 | News
Coya Therapeutics Demonstrates Promising CNS Anti-Inflammatory Effects of COYA 302 in Parkinson’s Disease Model
A key aspect of Parkinson’s disease (PD) pathophysiology is decreased systemic regulatory T cell (Treg) function with associated neuroinflammat...
September 17, 2024 | News
Vimgreen Pharmaceuticals Completes Enrollment for Phase 2 Trial of Novel A2A Receptor Antagonist in Parkinson's Disease
Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced the completion of enrollment ...
August 16, 2024 | News
UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare
Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...
August 14, 2024 | News
Genova Diagnostics Launches Innovative Non-Invasive Alzheimer's Blood Test in Strategic Partnership with Neurocode
Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of its groundbreaking Alzheimer's Assessment, a non...
August 12, 2024 | News
Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
Eisai and EcoNaviSta Join Forces to Develop Dementia Ecosystem in Japan’s Super-Aging Society
Eisai Co., Ltd. and EcoNaviSta Inc. announced that they have entered into a business alliance agreement and commenced collaboration with the aim of buildin...
July 25, 2024 | News
CUHK Faculty of Medicine Identifies Gut Microbial Markers for Autism Diagnosis
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and w...
July 12, 2024 | News
FDA Approves Donanemab for Early Alzheimer's: C2N Diagnostics' Biomarkers Play Crucial Role in Landmark Study
C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking today’s decision by the U.S. Food and Drug Administration to appr...
July 03, 2024 | News
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
